bibliographic entry 4978111 [be/4978111]
https://w3id.org/oc/corpus/be/4978111

is a

• bibliographic reference

content

• Kastritis E, Roussou M, Gavriatopoulou M, Migkou M, Kalapanida D, Pamboucas C et al. Long-term outcomes of primary systemic light chain (AL) amyloidosis in patients treated upfront with bortezomib or lenalidomide and the importance of risk adapted strategies. Am J Hematol 2015; 90: E60–E65. PMID: 25580702

references

• https://w3id.org/oc/corpus/br/4539232